REMICADE® is a complex biologic medicine that cannot be copied exactly. So even though infliximab biosimilars are very similar to REMICADE®, that doesn't mean they are interchangeable with REMICADE®.
To date, according to the US Food and Drug Administration (FDA), no infliximab biosimilar has been proven to be interchangeable with REMICADE®.
It will work the same as REMICADE® for anyone who takes it—no infliximab biosimilar has yet proven this.
Switching or alternating back and forth between the interchangeable biologic and REMICADE® would not cause any changes in safety or how well the treatment works—no infliximab biosimilar has yet proven this.
Then make your voice heard! Remember to download our Doctor Discussion Guide to help you talk with your doctor to see if staying on REMICADE® is right for you.
Download the guideREMICADE® is a prescription medication used to treat:
Only your doctor can recommend a course of treatment after checking your health condition. REMICADE® (infliximab) can cause serious side effects such as lowering your ability to fight infections. Some patients, especially those 65 years and older, have had serious infections caused by viruses, fungi or bacteria that have spread throughout the body, including tuberculosis (TB) and histoplasmosis. Some of these infections have been fatal. Your doctor should monitor you closely for signs and symptoms of TB during treatment with REMICADE®.
Unusual cancers have been reported in children and teenage patients taking TNF-blocker medicines. Hepatosplenic T-cell lymphoma, a rare form of fatal lymphoma, has occurred mostly in teenage or young adult males with Crohn’s disease or ulcerative colitis who were taking REMICADE® and azathioprine or 6-mercaptopurine. For children and adults taking TNF blockers, including REMICADE®, the chances of getting lymphoma or other cancers may increase. You should discuss any concerns about your health and medical care with your doctor.
You should let your doctor know if you have or ever had any of the following:
Also tell your doctor if you:
The following serious (sometimes fatal) side effects have been reported in people taking REMICADE®. You should tell your doctor right away if you have any of the signs listed below:
The most common side effects of REMICADE® include respiratory infections (that may include sinus infections and sore throat), headache, rash, coughing and stomach pain.
Please read the full Prescribing Information and Medication Guide for REMICADE® and discuss any questions you have with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
073798-170531
REMICADE® is a prescription medication used to treat:
© Janssen Biotech, Inc. 2017. All rights reserved.
This site is published by Janssen Biotech, Inc., which is solely responsible for its contents. The material on this site is intended only as informational or as an educational aid and it is not intended to be taken as medical advice. The ultimate responsibility for patient care resides with a healthcare professional.
This information is intended for the use of patients and caregivers in the United States and Puerto Rico only. Laws, regulatory requirements, and medical practices for pharmaceutical products vary from country to country. The Prescribing Information included here may not be appropriate for use outside the United States and Puerto Rico.
Capitalized product names are trademarks of Janssen Biotech, Inc.
Last Updated March 24, 2017